Can tigecycline raise liver enzymes (transaminases)?
Yes. Tigecycline can cause liver-test abnormalities, including increases in transaminases (AST and ALT). These elevations are part of the drug’s reported adverse effects and are monitored during treatment.
What transaminase-related lab changes are reported?
The main transaminase concern is an increase in AST/ALT on blood tests. This can occur even without obvious symptoms, so clinicians typically follow liver function tests during therapy.
Is this different from other common tigecycline side effects?
Tigecycline is also associated with a range of other adverse effects (for example, gastrointestinal effects), but transaminase elevations are specifically relevant because they reflect possible liver involvement. The key point for patients and clinicians is that liver enzymes can go up during treatment and should be tracked.
Who is at higher risk of tigecycline liver enzyme elevations?
People with pre-existing liver disease or those receiving prolonged treatment may be more likely to develop liver-test abnormalities, so monitoring is especially important in these settings.
What symptoms should prompt urgent medical attention?
If transaminase elevations occur with symptoms of liver injury, patients should seek medical care promptly. Common warning signs include jaundice (yellow eyes/skin), dark urine, severe fatigue, right upper abdominal pain, or new nausea/vomiting.
What do clinicians usually do if transaminases rise?
Clinicians typically recheck liver tests and assess severity and timing relative to tigecycline. If elevations are significant or accompanied by symptoms, they may reduce dose, pause therapy, or stop the drug depending on clinical judgment and alternative options.
Sources cited
No source links were provided with the question, so I can’t cite specific package-insert or study references here. If you share the tigecycline label/study you’re using (or the country/brand name), I can pinpoint the exact transaminase adverse-effect wording and rates.